Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03329248
Title QUILT-3.060: Combination Immunotherapy With High-affinity Natural Killer (haNK) in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy.
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NantKwest, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.